Literature DB >> 22076619

In response to "Clinical features and management of carboplatin-related hypersensitivity reactions in pediatric low grade glioma".

Lucie Lafay-Cousin, Eric Bouffet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22076619     DOI： 10.1007/s00520-011-1309-3

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  4 in total

1.  Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma.

Authors:  Eric Bouffet; Regina Jakacki; Stewart Goldman; Darren Hargrave; Cynthia Hawkins; Manohar Shroff; Juliette Hukin; Ute Bartels; Nicholas Foreman; Stewart Kellie; Joanne Hilden; Michael Etzl; Beverly Wilson; Derek Stephens; Uri Tabori; Sylvain Baruchel
Journal:  J Clin Oncol       Date:  2012-03-05       Impact factor: 44.544

2.  Weekly vinblastine in pediatric low-grade glioma patients with carboplatin allergic reaction.

Authors:  Lucie Lafay-Cousin; Stefan Holm; Ibrahim Qaddoumi; Gary Nicolin; Ute Bartels; Uri Tabori; Annie Huang; Eric Bouffet
Journal:  Cancer       Date:  2005-06-15       Impact factor: 6.860

3.  Carboplatin hypersensitivity reaction in pediatric patients with low-grade glioma: a Canadian Pediatric Brain Tumor Consortium experience.

Authors:  Lucie Lafay-Cousin; Lillian Sung; Anne-Sophie Carret; Juliette Hukin; Beverly Wilson; Donna L Johnston; Shayna Zelcer; Mariana Silva; Isaac Odame; Chris Mpofu; Douglas Strother; Eric Bouffet
Journal:  Cancer       Date:  2008-02-15       Impact factor: 6.860

4.  Specific IgE antibodies to platinum salts in sensitized workers.

Authors:  O Cromwell; J Pepys; W E Parish; E G Hughes
Journal:  Clin Allergy       Date:  1979-03
  4 in total
  1 in total

1.  Re: In response to "Clinical features and management of carboplatin-related hypersensitivity reactions in pediatric low grade glioma".

Authors:  Dildar Bahar Genc; Cengiz Canpolat; Su Gulsun Berrak
Journal:  Support Care Cancer       Date:  2012-03-07       Impact factor: 3.603
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.